Allegro Ophthalmics
Dr. Kurtz is the president and CEO of RxSight (formerly Calhoun Vision), and developer of a proprietary intraocular lens (IOL) that can be enhanced post-operatively to reduce spectacle dependence. He was previously co-founder, president and CEO of LenSx Lasers Inc., which was acquired by Alcon in 2010, and of IntraLase Corporation, which was acquired by Advanced Medical Optics in 2008.
A retina specialist, Dr. Kurtz served on the faculty at the University of Michigan and the University of California, Irvine. Dr. Kurtz earned his BA in biochemistry from Harvard College and his MD from the University of California, San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Allegro Ophthalmics
Allegro Ophthalmics, LLC is a late-stage ophthalmic biopharmaceutical company focused on redefining the retina space with integrin inhibition therapy, a potential market-disrupting class of drugs for the treatment of retinal diseases.